Viewing Study NCT01856192


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2025-12-30 @ 3:44 AM
Study NCT ID: NCT01856192
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-28
First Post: 2013-05-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization: